Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications.

1350462-55-3

C38H52N6O10S

784.92

MK-5172;MK 5172;Grazoprevir;MK5172;Grazoprevir hydrate

H2O:Insoluble
DMSO:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years